Serum HMGB1 Associates with Liver Disease and Predicts Readmission and Mortality in Patients with Alcohol Use Disorder.
Sign Up to like & getrecommendations! Published in 2021 at "Alcohol"
DOI: 10.1016/j.alcohol.2021.05.003
Abstract: Identifying the minority of patients with Alcohol Use Disorder (AUD) who develop the wide spectrum of Alcohol-associated Liver Disease (ALD), and risk stratifying these patients, is of critical importance. High-Mobility Group Box 1 protein (HMGB1)… read more here.
Keywords: hmgb1; liver disease; patients aud; serum hmgb1 ... See more keywords